The 19th edition of Medical Taiwan concluded with strong international engagement, bringing together 316 exhibitors from 14 countries and more than 7,600 professional visitors from 52 countries. The top buyer markets included Japan, China, South Korea, Thailand, and the United States, reflecting the show’s appeal to key international healthcare markets. In addition to the exhibition, over 45 stage presentations and 10 professional forums were held, including the Medical Taiwan 2025 Forum, M-novator Demo Day, Taiwan-Japan Home Healthcare Business Forum, and Bio Day 2025, drawing the attention of major industry stakeholders and decision-makers. Many exhibitors reported that the show exceeded their expectations, particularly in terms of generating high-value connections with international buyers. This underscores Medical Taiwan’s growing reputation as a premier platform for global healthcare innovation, trade, and collaboration.